The corporate acquisition of Tamro and Medaffcon opens up new opportunities for the utilisation of medical information in the impact assessment of pharmaceuticals and healthcare

The corporate acquisition of Tamro and Medaffcon opens up new opportunities for the utilisation of medical information in the impact assessment of pharmaceuticals and healthcare

News

The corporate acquisition of Tamro and Medaffcon opens up new opportunities for the utilisation of medical information in the impact assessment of pharmaceuticals and healthcare

Medaffcon is a research and expert service company established in 2009, which works in the field of medicine and healthcare and employs 22 experts. Medaffcon is a solid expert in medical and health economical services. The company has pioneered in conducting the first commercial biobank studies in Finland and in developing assessment methods to evaluate treatment effectiveness. Medaffcon’s turnover was 2.5 M€ in 2016, and firm growth is expected for 2017.

Tamro has already a solid view and experience in developing and connecting the entire chain of medical treatment. Our own expertise in the utilisation of medical data brings extent to Tamro’s service provision. Tamro’s shoulders also support us in our growth and internationalisation targets. It is great to together export Finnish healthcare knowledge to the world, stated Medaffcon’s Managing Director Jarmo Hahl.

Read the entire article here.


Related posts